Healthcare ACtive Runners: Teva Pharmaceutical Industries (NYSE:TEVA), Exelixis (NASDAQ:EXEL), Novavax (NASDAQ:NVAX), Abbott Laboratories (NYSE:ABT), Celgene (NASDAQ:CELG)

Just a month ago, Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) snapped up portfolio company, San Mateo, CA-based Labrys Biologics, for $200 million up front and another $625 million in milestones. That deal came less than two years after Labrys was formed, and venBio partner and co-founder Corey Goodman told Xconomy at the time that venBio had contributed $8.5 million of Labrys’ $31 million Series A round plus an … Continue reading Healthcare ACtive Runners: Teva Pharmaceutical Industries (NYSE:TEVA), Exelixis (NASDAQ:EXEL), Novavax (NASDAQ:NVAX), Abbott Laboratories (NYSE:ABT), Celgene (NASDAQ:CELG)

Biotech Bearish Stocks: MannKind Corporation (NASDAQ:MNKD), Exelixis (NASDAQ:EXEL), Inovio Pharmaceuticals (NYSEMKT:INO), EXACT Sciences (NASDAQ:EXAS)

An FDA report raised questions regarding Mannkind Corporation (NASDAQ:MNKD)’s diabetes device Afrezza ahead of an April 1 meeting of outside advisers to the FDA. The drug has yet to be approved by the FDA as there are concerns over certain pharmacology issues that could impact Afreeza’s safety and effectiveness. MannKind Corporation (NASDAQ:MNKD) stock performance was -7.12% in last session and finished the day at $4.83. … Continue reading Biotech Bearish Stocks: MannKind Corporation (NASDAQ:MNKD), Exelixis (NASDAQ:EXEL), Inovio Pharmaceuticals (NYSEMKT:INO), EXACT Sciences (NASDAQ:EXAS)

Over the past few trading days, sleepy microcap Aastrom Biosciences Inc (NASDAQ:ASTM) has exploded from $3.88 3/19/14 to a peak of $6.24 after a positive article from respected analyst Jason Napodano. Seeking Alpha’s sophisticated readership is more than capable of analyzing Aastrom Biosciences Inc (NASDAQ:ASTM)’s balance sheet. Aastrom Biosciences Inc (NASDAQ:ASTM) stock performance was -15.21% in last session and finished the day at $4.18. Traded … Continue reading Unusual Volume At Biotech Stocks: Aastrom Biosciences (NASDAQ:ASTM), 22nd Century Group (NYSEMKT:XXII), Dyax Corp. (NASDAQ:DYAX), Exelixis (NASDAQ:EXEL)

Plug Power Inc. (NASDAQ:PLUG) the fuel-cell maker was in the news again yesterday, after CEO Andy Marsh told MarketWatch that the company had “signed an additional order in North America with a global automaker. Plug Power Inc. (NASDAQ:PLUG) stock performance was -23.94% in last session and finished the day at $6.45. Traded volume was 119.25 million shares in the last session and the average volume … Continue reading Top Losers: Plug Power Inc. (NASDAQ:PLUG), Facebook Inc. (NASDAQ:FB), Exelixis (NASDAQ:EXEL), FuelCell Energy Inc. (NASDAQ:FCEL)

On Dec 15, Exelixis, Inc. (NASDAQ:EXEL) announced its collaborator Genentech, a member of the Roche Group, has completed the filing of its New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) for cobimetinib, a specific MEK inhibitor discovered by Exelixis, in combination with vemurafenib for previously untreated patients with unresectable locally advanced or metastatic melanoma harboring a BRAF V600 mutation. Exelixis, Inc. … Continue reading Market Wrap Up: Exelixis, Inc. (NASDAQ:EXEL), Sirius XM Holdings Inc. (NASDAQ:SIRI), Genocea Biosciences, Inc. (NASDAQ:GNCA), People’s United Financial (NASDAQ:PBCT), Atlantic Tele-Network (NASDAQ:ATNI)

On Dec 22, Staples, Inc. (NASDAQ:SPLS) says nearly 1.2 million customer payment cards may have been exposed during a security breach earlier this year. The office supply retailer announced in October that it was looking into a potential credit card breach, adding to a long list of retailers recently hit by cyberattacks. Staples, Inc. (NASDAQ:SPLS) belongs to Services sector. Its net profit margin is 2.70% … Continue reading Investor’s Choice: Staples, Inc. (NASDAQ:SPLS), Exelixis, Inc. (NASDAQ:EXEL), NTT DOCOMO, Inc. (NYSE:DCM), Splunk, Inc. (NASDAQ:SPLK), Air Methods Corp. (NASDAQ:AIRM)